Exact Mass: 711.383
Exact Mass Matches: 711.383
Found 17 metabolites which its exact mass value is equals to given mass value 711.383,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ipamorelin
6-amino-2-(2-{2-[2-(2-amino-2-methylpropanamido)-3-(3H-imidazol-4-yl)propanamido]-3-(naphthalen-2-yl)propanamido}-3-phenylpropanamido)hexanamide
cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)
cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)
Ipamorelin
H-Aib-DL-His-DL-2Nal-DL-Phe-DL-Lys-NH2
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue
(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane
(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane
LCKLSL (hydrochloride)
LCKLSL (hydrochloride)
LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles[1].
19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
